A TRAIL-R1-specific ligand in combination with doxorubicin selectively targets primary breast tumour cells for apoptosis
conference contribution
posted on 2016-04-18, 12:02 authored by D. Twiddy, S. Naik, R. Mistry, J. Edwards, Rosemary Ann Walker, G. M. Cohen, M. MacFarlaneA TRAIL-R1-specific ligand in combination with doxorubicin selectively targets primary breast tumour cells for apoptosis
History
Citation
Breast Cancer Research, 2010, 12, pp. S17-S18 (2)Author affiliation
/Organisation/COLLEGE OF MEDICINE, BIOLOGICAL SCIENCES AND PSYCHOLOGY/MBSP Non-Medical Departments/Old Departments Pre 01 Aug 2015/Department of Biochemistry (Pre 01 Aug 2015)Source
Conference on Breast Cancer Research, London, ENGLANDVersion
- VoR (Version of Record)
Published in
Breast Cancer ResearchPublisher
BioMed Centralissn
1465-5411eissn
1465-542XCopyright date
2010Available date
2016-04-18Publisher DOI
Publisher version
http://breast-cancer-research.biomedcentral.com/articles/10.1186/bcr2555Temporal coverage: start date
2010-05-18Language
enAdministrator link
Usage metrics
Categories
No categories selectedLicence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC